Save this page
Save this page

My Saved Pages

  • Saved page.

My Saved Courses

  • Saved page.

Recently visited

  • Saved page.

Professor Nigel Pyne

Strathclyde Institute of Pharmacy and Biomedical Sciences

Personal statement

Awards: 1995 Sandoz Prize in Pharmacology (awarded by the British Pharmacological Society)

              2010 Elected Member of Academy of Sciences of the Institute of Bologna (affilated with the University of Bologna, founded in 1690)

              2017 Elected Fellow of the Rotal Society of Biology (FRSB)


Research interests

  • Lysolipid (sphingosine 1-phosphate, lysophoshatidic acid) receptor signalling in health and disease with specific focus on cancer and cardiovascular/inflammatory disease
  • Cross talk regulation between lysolipid receptors and growth factor receptors/oncogenes (e.g. PDGFR, HER2, EGFR and TRK A)
  • Translational biology of lysolipids (e.g. drug discovery and biomarker identification)
  • Cyclic AMP/cyclic GMP signalling

The overall aim of research is to investigate the molecular mechanisms by which lysolipid receptors regulate cell biology; to determine how these mechanisms become altered in diseases and to evaluate the potential of receptors and enzymes involved in lysolipid signalling as drugable targets. Techniques in the laboratory range from in vitro cell based assays, imaging, mass spectroscopic analysis and proteomics to in vivo analysis. Recent research in this laboratory has received support from Cancer Research UK, British Heart Foundation, Biotechnology and Biological Sciences Research Council and industry.

175 papers published with an H index of 51 and with ~8100 citations (Google Scholar Citations).

Co-founder of Mironid Ltd

Executive member, SULSA

Head of Research, SIPBS (Aug 2006-Sept 2008)

Teaching Activity: lectures, workshops and tutorials to undergraduates of the BSc (various biological science) and MPharm (pharmacy) teaching programmes. Supervision of laboratory based research projects at both undergraduate and postgraduate (PhD) level.


Sphingosine kinase1 : a potential therapeutic target in pulmonary arterial hypertension?
Pyne Nigel J., Pyne Susan
Trends in Molecular Medicine Vol 23, pp. 786-798, (2017)
Sphingosine 1-phosphate and cancer
Pyne Nigel J., El Buri Ashref, Adams David R., Pyne Susan
Advances in Biological Regulation, (2017)
Sphingosine kinase 2 in autoimmune/inflammatory disease and development of sphingosine kinase 2 inhibitors
Pyne Nigel J., Adams David R., Pyne Susan
Trends in Pharmacological Sciences Vol 38, pp. 581-591, (2017)
Sphingosine kinase 2 and multiple myeloma
Pyne Nigel J., Pyne Susan
Oncotarget Vol 8, pp. 43596-43597, (2017)
Sphingosine 1-phosphate receptor 1 signaling in mammalian cells
Pyne Nigel J., Pyne Susan
Molecules Vol 22, pp. 1-18, (2017)
Effect of sphingosine kinase modulators on interleukin-1β release, sphingosine 1-phosphate receptor 1 expression and experimental autoimmune encephalomyelitis : FTY720 analogues and inflammation
Barbour Mark, McNaughton Melissa, Boomkamp Stephanie D., MacRitchie Neil, Jiang Hui-Rong, Pyne Nigel J, Pyne Susan
British Journal of Pharmacology Vol 174, pp. 210-222, (2017)

more publications

Professional activities

Special International Symposium “Current Trends in Cancer and Signalling' (Ulsan, Korea)
Role of Sphingosine kinases in Cell Biology, HKUST
Role of Sphingosine kinases in Cell Biology, CPU
Teaching at CPU
External Examiner
Teaching at the Chinese Pharmaceutical University
External Examiner
FASEB Meeting on Lysolipids

more professional activities


The role of sphingosine 1-phosphate in colorectal cancer
Pyne, Susan (Principal Investigator) Pyne, Nigel (Co-investigator)
Period 16-May-2011 - 31-Jul-2014
The Role Of S1P4 And SK1 In Triple Negative Breast Cancer
Pyne, Nigel (Principal Investigator) Dufes, Christine (Co-investigator) Pyne, Susan (Co-investigator)
Period 06-Feb-2013 - 05-Feb-2014
Novel signalling by nuclear LPA receptors
Pyne, Nigel (Principal Investigator) Pyne, Susan (Co-investigator)
Period 01-May-2006 - 30-Apr-2009
Identification of pre-clinical SK1 inhibitors for the treatment of Pulmonary Hypertension
Pyne, Nigel (Principal Investigator) MacKay, Simon (Co-investigator) Pyne, Susan (Co-investigator)
Period 26-Oct-2013 - 25-Oct-2014
Pyne, Nigel (Co-investigator)
Period 12-Oct-2004 - 31-Dec-2007
Quantitative analysis of the regulation of gene expression, changes in posttranslational protein modifications and protein:protein interactions
Lawrence, Catherine (Co-investigator) Pyne, Susan (Co-investigator) Pyne, Nigel (Co-investigator) Roberts, Craig (Co-investigator)
Period 01-Mar-2003 - 28-Feb-2008

more projects


Strathclyde Institute of Pharmacy and Biomedical Sciences
John Arbuthnott Building Robertson Wing

Location Map

View University of Strathclyde in a larger map